Genetic Engineering and Tissue Engineering
Genetic engineering is the manipulation of an organism's genome using biotechnology Principles. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species domains for the production of improved or novel organisms. Genetic engineering has applications in medicine, research, industry and agriculture and can be used on a wide range of plants, animals and microorganisms. Tissue engineering is the use of a integration of cells, engineering and materials principles, and suitable biochemical and physicochemical factors to improve or replace biological tissues. It involves the use of a scaffold for the formation of new viable tissue for a medical purpose. Tissue engineering covers a broad range of applications, that repair or replace portions of or whole tissues (i.e., bone, cartilage, blood vessels, bladder, skin, muscle etc.). The definition of regenerative medicine is often used same sense with tissue engineering, although those involved in regenerative medicine place more emphasis on the use of stem cells or progenitor cells to produce tissues.
Related Conference of Genetic Engineering and Tissue Engineering
20th World Congress on Biomarkers, Cancer Therapy & Clinical Research
7th Annual Congress on Biosimilars and Future Biotherapeutics
41st International Conference on Next-Gen Biotechnology and Applications
Genetic Engineering and Tissue Engineering Conference Speakers
Recommended Sessions
- Animal Biotechnology
- Applied Biotechnology
- Bio-Safety and Bioethics
- Bioinformatics and Biomedicine Engineering
- Biomedical Engineering and Bio-Engineering
- Enzyme and Protein Engineering
- Food & Feed Biotechnology
- Genetic Engineering and Tissue Engineering
- Industrial and Microbial Biotechnology
- Marine, Aquatic and Ocean Biotechnology
- Medicine & Biotechnology
- Molecular Biotechnology
- Nano biotechnology
- Pharmaceutical Biotechnology
- Plant, Agriculture and Environment Biotechnology
Related Journals
Are you interested in
- 3D Bioprinting & Regenerative Medicine - Biotechnology- 2025 (France)
- Advancements in Biosimilar Development Technologies - Biosimilars 2026 (France)
- Advances in Genomic Biotechnology - Biotechnology 2025 (Spain)
- AI in Drug Discovery - Biotechnology- 2025 (France)
- AI in Vaccine Development - Biotechnology- 2025 (France)
- AI-Powered Precision Medicine - Biotechnology- 2025 (France)
- Artificial Intelligence and Digital Tools in Biotherapeutics - Biosimilars 2026 (France)
- Bio-Cybernetics & Smart Implants - Biotechnology- 2025 (France)
- Biobetters: The Next Generation of Biologics - Biosimilars 2026 (France)
- Bioethics in Biotechnology 5.0 - Biotechnology- 2025 (France)
- Bioinformatics & Big Data - Biotechnology- 2025 (France)
- Biomedical Biotechnology - Biotechnology 2025 (Spain)
- Biopharmaceuticals and Biosimilars - Biotechnology 2025 (Spain)
- Biosimilar Market Access and Reimbursement Policies - Biosimilars 2026 (France)
- Biosimilars in Oncology and Autoimmune Diseases - Biosimilars 2026 (France)
- Biosimilars in Rare and Orphan Diseases - Biosimilars 2026 (France)
- Biotechnology and Global Health - Biotechnology 2025 (Spain)
- Biotechnology in Agriculture - Biotechnology 2025 (Spain)
- Biotechnology in Space - Biotechnology- 2025 (France)
- Blockchain for Biotech Data Security - Biotechnology- 2025 (France)
- Brain-Computer Interfaces & Neurobiotech - Biotechnology- 2025 (France)
- Clinical Trials & Comparability Studies for Biosimilars - Biosimilars 2026 (France)
- Collaborative Models in Biosimilar Development - Biosimilars 2026 (France)
- Computational and Systems Biology - Biotechnology 2025 (Spain)
- Cost-Effectiveness and Health Economics of Biosimilars - Biosimilars 2026 (France)
- CRISPR & Beyond - Biotechnology- 2025 (France)
- Environmental Biotechnology - Biotechnology 2025 (Spain)
- Evolving Trends and Innovations in Biosimilar Development and Access - Biosimilars 2026 (France)
- Formulation and Delivery Systems for Biologics - Biosimilars 2026 (France)
- Future Biotherapeutics: Cell and Gene Therapies - Biosimilars 2026 (France)
- Future of AgriTech - Biotechnology- 2025 (France)
- Future of Monoclonal Antibodies and Fusion Proteins - Biosimilars 2026 (France)
- Future Trends in Biotechnology - Biotechnology 2025 (Spain)
- Global Trends and Challenges in Biosimilar Adoption - Biosimilars 2026 (France)
- Immunogenicity Assessment and Risk Management - Biosimilars 2026 (France)
- Industrial Biotech & Smart Biofactories - Biotechnology- 2025 (France)
- Industrial Biotechnology - Biotechnology 2025 (Spain)
- Industrial Scale-Up and Bioprocessing - Biotechnology 2025 (Spain)
- Interchangeability and Substitution Policies - Biosimilars 2026 (France)
- Manufacturing and Quality Control of Biosimilars - Biosimilars 2026 (France)
- Marine Biotechnology - Biotechnology 2025 (Spain)
- Microbial Biotechnology - Biotechnology 2025 (Spain)
- Nanotechnology in Medicine - Biotechnology- 2025 (France)
- Patient and Physician Perspectives on Biosimilar Use - Biosimilars 2026 (France)
- Personalized Nutrition & Gut Microbiome - Biotechnology- 2025 (France)
- Pharmacovigilance and Post-Marketing Surveillance - Biosimilars 2026 (France)
- Quantum Computing in Biotech - Biotechnology- 2025 (France)
- Regulatory Pathways and Global Harmonization - Biosimilars 2026 (France)
- Smart Biomanufacturing - Biotechnology- 2025 (France)
- Stem Cell and Regenerative Medicine - Biotechnology 2025 (Spain)
- Sustainable Biotech Innovations - Biotechnology- 2025 (France)
- Synthetic Biology and Bioengineering - Biotechnology 2025 (Spain)
- Synthetic Biology: Reprogramming Life - Biotechnology- 2025 (France)
- The Future of Biotech Startups - Biotechnology- 2025 (France)
- Vaccine Development and Immunotherapy - Biotechnology 2025 (Spain)